Advertisement
Journal Home
Search for

Volume 33, Issue 6, Pages 433-438 (November 2009)


View previous. 5 of 38 View next.

Contrast-enhanced CT colonography with 64-slice MDCT compared to endoscopic colonoscopy in the follow-up of patients after colorectal cancer resection

Marianne Michal AmitaiaCorresponding Author Informationemail address, Herma Fidderb, Benjamin Avidanb, Orith Portnoya, Sara Aptera, Eli Konena, Marjorie Hertza

Received 24 November 2008; accepted 8 January 2009. published online 01 April 2009.

Abstract 

Background

Seventy percent of newly diagnosed colorectal cancer cases are potential candidates for curative surgery, but after resection, in 30%, the tumor will recur.

Postoperative follow-up includes endoscopic colonoscopy (EC) and computed tomography (CT). There have been only a few publications on the use of contrast-enhanced CT colonography (CECTC) in the follow-up of these patients.

Methods

Twenty-nine consecutive patients after resection of colorectal cancer underwent CECTC and EC on the same day. CECTC studies were reviewed for identification of strictures, recurrence, polyps and metastases.

Results

The anastomosis was identified in 96% of patients on CECTC and in 82% on endoscopic colonoscopy. One stricture was identified by both techniques. One extraluminal recurrence was depicted only on CECTC. Sensitivity in detecting polyps was per polyp 93% and per patient 100%.

Conclusion

CECTC performed on a 64-slice multidetector CT is reliable in imaging the postoperative colon for the follow-up of patients after resection of colorectal cancer.

a Department of Diagnostic Imaging, Chaim Sheba Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

b Department of Gastroenterology, Chaim Sheba Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Corresponding Author InformationCorresponding author. Department of Diagnostic Imaging, Chaim Sheba Medical Center, 52621, Tel Hashomer, Israel. Tel.: +972 52 6666651; fax: +972 3 5357315.

PII: S0899-7071(09)00010-2

doi:10.1016/j.clinimag.2009.01.002


View previous. 5 of 38 View next.

Advertisement